The invention discloses a pharmaceutical composition containing
phyllanthus emblica. The pharmaceutical composition comprises the effective component a, which comprises the following raw materials in parts by weight: 10 to 30 parts of
phyllanthus emblica, 1 to 10 parts of medlar, 1 to 10 parts of folium mori, 1 to 10 parts of
lotus leaf, 1 to 10 parts of chrysanthemum, 1 to 10 parts of rhizoma
polygonatum, 1 to 10 parts of ginger and 1 to 10 parts of liquorice. The pharmaceutical composition has obvious antibacterial, anti-
virus and anti-inflammatory effects, and improves the
immunity of the body. In addition, the pharmaceutical composition has the functions of clearing away heat and detoxifying, nourishing yin and moistening
dryness, replenishing qi and blood, replenishing
kidney and
spleen, and not only helping to restore the normal body temperature, and adjust the internal environment, and strengthen the
body resistance to eliminate pathogenic factors, is a good
medicine for the treatment of AIDS that has the remarkable effect and no adverse reactions and side effects, and is suitable for long-term intervention, and
raw material resources are easily available.